ELF3 promotes the development of psoriasis through transcriptional up-regulation of ADAM8 expression
Immunology Letters · 2026
DOI: 10.1016/j.imlet.2025.107069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology Letters, 2026. Verfasst von Yu Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, PR China. Electronic address: 900155@hrbmu.edu…. Hauptthemen laut MEDLINE: Psoriasis, Proto-Oncogene Proteins c-ets, Membrane Proteins, Transcription Factors. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Health Commission of Heilongjiang Province.
Abstract (Originalsprache)
Psoriasis is a systemic inflammatory disorder that has a significant impact on the quality of life of patients. E74-like factor 3 (ELF3) is a common transcriptional mediator of inflammation, but the effect of ELF3 on psoriasis development and severity is poorly understood. In this study, we first collected clinical normal skin tissues and skin tissues of psoriasis patients to detect the mRNA and protein levels of ELF3 and found that ELF3 was highly expressed in psoriasis skin tissues. We further used the imiquimod (IMQ)-induced mice model to mimic the phenotypic changes of human psoriasis in vivo, which are manifested as scaling, epidermal hyperplasia, and erythema formation, but knockdown of ELF3 resulted in suppression of these phenomena. In addition, downregulation of ELF3 expression inhibited neoangiogenesis and inflammatory cell infiltration. On this basis, we further found that ELF3 promotes the proliferation, angiogenesis, and inflammatory response of human keratinocyte HaCaT in vitro. Mechanistically, we found that ELF3 transcriptionally activated the activity of the downstream factor ADAM metallopeptidase domain 8 (ADAM8) by dual luciferase assays, thereby exacerbating the severity of psoriasis. We concluded that ELF3 is a key target for exacerbating psoriasis pathologic manifestations and promoting disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, PR China. Electronic address: 900155@hrbmu.edu.cn.
- Department of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, PR China. Electronic address: tusi871161@163.com.
- Department of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, PR China. Electronic address: haosiyu@hrbmu.edu.cn.
- Department of Dermatology, Harbin Medical University, Harbin 150081, PR China. Electronic address: 2022021145@hrbmu.edu.cn.
- Department of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150001, PR China. Electronic address: liyuzhenchina@126.com.
Förderung
- Health Commission of Heilongjiang Province
Zitieren
APA
Zhang, Y., Tong, N., Hao, S., Ma, H., & Li, Y. (2026). ELF3 promotes the development of psoriasis through transcriptional up-regulation of ADAM8 expression. Immunology Letters. https://doi.org/10.1016/j.imlet.2025.107069
Vancouver
Zhang Y, Tong N, Hao S, Ma H, Li Y. ELF3 promotes the development of psoriasis through transcriptional up-regulation of ADAM8 expression. Immunology Letters. 2026. doi:10.1016/j.imlet.2025.107069
BibTeX
@article{Zhang2026,
author = {Zhang, Yu and Tong, Nannan and Hao, Siyu and Ma, He and Li, Yuzhen},
title = {ELF3 promotes the development of psoriasis through transcriptional up-regulation of ADAM8 expression},
journal = {Immunology Letters},
year = {2026},
doi = {10.1016/j.imlet.2025.107069}
}
EUVIMED